Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

Jennifer I. Hare, Elaine H. Moase, Theresa M. Allen

Journal of drug targeting · 2012 · 25 citations · 26 references

Abstract

Proof-of-concept studies revealed the therapeutic potential of a dual-targeted two drug approach against HER2-positive breast cancer, and may be applicable to the treatment of other solid tumors.

References

26